Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Menorrhagia 7Leiomyoma 7Breast Neoplasms 6Polycystic Ovary Syndrome 4Vaginitis 1Sexual Dysfunction, Physiological 1Postmenopausal Vaginal Atrophy 1Neoplasms 1Infertility 1Hyperandrogenism 1Estrogen Levels Among Breast Cancer Patients 1Breast Carcinoma In Situ 1Atrophic Vaginitis 1

Interventions

Estradiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Postmenopausal Vaginal Atrophy × Estradiol × Clear all
NCT05243823 2022-12-23

Vaginal Estradiol Tablets (Vagifem®) and Endometrial Cancer Risk in the Treatment of Postmenopausal Vaginal Atrophy

Novo Nordisk A/S

Completed
500,000 enrolled

Postmenopausal Vaginal Atrophy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡